Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - Summary of Stock Option Activities (Details)

v3.23.1
Stock-Based Compensation - Summary of Stock Option Activities (Details) - Options - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Options    
Outstanding - beginning balance (in shares) 7,603,864  
Granted (in shares) 0  
Exercised (in shares) (300,785)  
Forfeited (in shares) 0  
Outstanding - ending balance (in shares) 7,303,079 7,603,864
Exercisable at period end (in shares) 7,303,079  
Weighted Average Exercise Price    
Outstanding - beginning balance (in dollars per share) $ 0.19  
Granted (in dollars per share) 0  
Exercised (in dollars per share) 0.18  
Forfeited (in dollars per share) 0  
Outstanding - ending balance (in dollars per share) 0.19 $ 0.19
Exercisable at period end (in dollars per share) 0.19  
Weighted Average Grant Date Fair Value    
Outstanding - beginning balance (in dollars per share) 0.21  
Granted (in dollars per share) 0  
Exercised (in dollars per share) 0.24  
Forfeited (in dollars per share) 0  
Outstanding - ending balance (in dollars per share) 0.21 $ 0.21
Exercisable at period end (in dollars per share) $ 0.21  
Additional Disclosures    
Weighted Average Remaining Life (years) 4 years 3 months 18 days 4 years 7 months 6 days
Weighted Average Remaining Life, Exercisable (years) 4 years 3 months 18 days  
Intrinsic Value $ 23,312 $ 25,795
Intrinsic Value, Exercisable $ 23,312